These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 15879497

  • 1. High incidence of skewed X chromosome inactivation in young patients with familial non-BRCA1/BRCA2 breast cancer.
    Kristiansen M, Knudsen GP, Maguire P, Margolin S, Pedersen J, Lindblom A, Ørstavik KH.
    J Med Genet; 2005 Nov; 42(11):877-80. PubMed ID: 15879497
    [Abstract] [Full Text] [Related]

  • 2. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
    Lose F, Duffy DL, Kay GF, Kedda MA, Spurdle AB, Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, Australian Ovarian Cancer Study Management Group.
    J Natl Cancer Inst; 2008 Nov 05; 100(21):1519-29. PubMed ID: 18957670
    [Abstract] [Full Text] [Related]

  • 3. BCoR-L1 variation and breast cancer.
    Lose F, Arnold J, Young DB, Brown CJ, Mann GJ, Pupo GM, Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, Khanna KK, Chenevix-Trench G, Spurdle AB.
    Breast Cancer Res; 2007 Nov 05; 9(4):R54. PubMed ID: 17697391
    [Abstract] [Full Text] [Related]

  • 4. Novel germline BRCA1 and BRCA2 mutations in Turkish women with breast and/or ovarian cancer and their relatives.
    Egeli U, Cecener G, Tunca B, Tasdelen I.
    Cancer Invest; 2006 Nov 05; 24(5):484-91. PubMed ID: 16939956
    [Abstract] [Full Text] [Related]

  • 5. The prevalence of germline BRCA1 and BRCA2 mutations in young women with breast cancer undergoing breast-conservation therapy.
    Golshan M, Miron A, Nixon AJ, Garber JE, Cash EP, Iglehart JD, Harris JR, Wong JS.
    Am J Surg; 2006 Jul 05; 192(1):58-62. PubMed ID: 16769276
    [Abstract] [Full Text] [Related]

  • 6. BRCA1 and BRCA2 status in a Central Sudanese series of breast cancer patients: interactions with genetic, ethnic and reproductive factors.
    Awadelkarim KD, Aceto G, Veschi S, Elhaj A, Morgano A, Mohamedani AA, Eltayeb EA, Abuidris D, Di Gioacchino M, Battista P, Verginelli F, Cama A, Elwali NE, Mariani-Costantini R.
    Breast Cancer Res Treat; 2007 Apr 05; 102(2):189-99. PubMed ID: 17333343
    [Abstract] [Full Text] [Related]

  • 7. [Mutational analysis of BRCA1 and BRCA2 genes in early-onset breast cancer patients in Shanghai].
    Song CG, Hu Z, Yuan WT, Di GH, Shen ZZ, Huang W, Shao ZM.
    Zhonghua Yi Xue Za Zhi; 2005 Nov 16; 85(43):3030-4. PubMed ID: 16324400
    [Abstract] [Full Text] [Related]

  • 8. [Study of BRCA1 and BRCA2 gene mutations in human sporadic breast cancers].
    Zhang HT, Lu YF, Zeng J, Lin J, Liao QH, Wan FQ.
    Zhonghua Wai Ke Za Zhi; 2007 Apr 01; 45(7):480-2. PubMed ID: 17686308
    [Abstract] [Full Text] [Related]

  • 9. Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping.
    Oldenburg RA, Kroeze-Jansema K, Meijers-Heijboer H, van Asperen CJ, Hoogerbrugge N, van Leeuwen I, Vasen HF, Cleton-Jansen AM, Kraan J, Houwing-Duistermaat JJ, Morreau H, Cornelisse CJ, Devilee P.
    Clin Cancer Res; 2006 Mar 15; 12(6):1693-700. PubMed ID: 16551851
    [Abstract] [Full Text] [Related]

  • 10. Selection bias influences reported contralateral breast cancer incidence and survival in high risk non-BRCA1/2 patients.
    Tilanus-Linthorst MM, Bartels KC, Alves C, Bakri B, Crepin E, van den Ouweland A, Klijn JG, Meijers-Heijboer H, Brekelmans CT.
    Breast Cancer Res Treat; 2006 Jan 15; 95(2):117-23. PubMed ID: 16319990
    [Abstract] [Full Text] [Related]

  • 11. High incidence of BRCA1-2 germline mutations, previous breast cancer and familial cancer history in Jewish patients with uterine serous papillary carcinoma.
    Biron-Shental T, Drucker L, Altaras M, Bernheim J, Fishman A.
    Eur J Surg Oncol; 2006 Dec 15; 32(10):1097-100. PubMed ID: 16650962
    [Abstract] [Full Text] [Related]

  • 12. High risk of contralateral breast carcinoma in women with hereditary/familial non-BRCA1/BRCA2 breast carcinoma.
    Shahedi K, Emanuelsson M, Wiklund F, Gronberg H.
    Cancer; 2006 Mar 15; 106(6):1237-42. PubMed ID: 16475207
    [Abstract] [Full Text] [Related]

  • 13. Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families.
    Giannini G, Capalbo C, Ristori E, Ricevuto E, Sidoni T, Buffone A, Cortesi E, Marchetti P, Scambia G, Tomao S, Rinaldi C, Zani M, Ferraro S, Frati L, Screpanti I, Gulino A.
    Breast Cancer Res Treat; 2006 Nov 15; 100(1):83-91. PubMed ID: 16847550
    [Abstract] [Full Text] [Related]

  • 14. BRCA1 and BRCA2 germline mutations in Korean breast cancer patients at high risk of carrying mutations.
    Ahn SH, Son BH, Yoon KS, Noh DY, Han W, Kim SW, Lee ES, Park HL, Hong YJ, Choi JJ, Moon SY, Kim MJ, Kim KH, Kwak BS, Cho DY.
    Cancer Lett; 2007 Jan 08; 245(1-2):90-5. PubMed ID: 16455195
    [Abstract] [Full Text] [Related]

  • 15. BRCA1 and BRCA2 mutations in Turkish familial and non-familial ovarian cancer patients: a high incidence of mutations in non-familial cases.
    Yazici H, Glendon G, Yazici H, Burnie SJ, Saip P, Buyru F, Bengisu E, Andrulis IL, Dalay N, Ozcelik H.
    Hum Mutat; 2002 Jul 08; 20(1):28-34. PubMed ID: 12112655
    [Abstract] [Full Text] [Related]

  • 16. CGH analysis of familial non-BRCA1/BRCA2 breast tumors and mutation screening of a candidate locus on chromosome 17q11.2-12.
    Maguire P, Holmberg K, Kost-Alimova M, Imreh S, Skoog L, Lindblom A.
    Int J Mol Med; 2005 Jul 08; 16(1):135-41. PubMed ID: 15942690
    [Abstract] [Full Text] [Related]

  • 17. A predictor based on the somatic genomic changes of the BRCA1/BRCA2 breast cancer tumors identifies the non-BRCA1/BRCA2 tumors with BRCA1 promoter hypermethylation.
    Alvarez S, Diaz-Uriarte R, Osorio A, Barroso A, Melchor L, Paz MF, Honrado E, Rodríguez R, Urioste M, Valle L, Díez O, Cigudosa JC, Dopazo J, Esteller M, Benitez J.
    Clin Cancer Res; 2005 Feb 01; 11(3):1146-53. PubMed ID: 15709182
    [Abstract] [Full Text] [Related]

  • 18. BRCA1 mutations and polymorphisms in a hospital-based consecutive series of breast cancer patients from Apulia, Italy.
    Tommasi S, Crapolicchio A, Lacalamita R, Bruno M, Monaco A, Petroni S, Schittulli F, Longo S, Digennaro M, Calistri D, Mangia A, Paradiso A.
    Mutat Res; 2005 Oct 15; 578(1-2):395-405. PubMed ID: 16026807
    [Abstract] [Full Text] [Related]

  • 19. Familial breast cancers without mutations in BRCA1 or BRCA2 have low cyclin E and high cyclin D1 in contrast to cancers in BRCA mutation carriers.
    Aaltonen K, Blomqvist C, Amini RM, Eerola H, Aittomäki K, Heikkilä P, Nevanlinna H.
    Clin Cancer Res; 2008 Apr 01; 14(7):1976-83. PubMed ID: 18381935
    [Abstract] [Full Text] [Related]

  • 20. Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study.
    Eisen A, Lubinski J, Klijn J, Moller P, Lynch HT, Offit K, Weber B, Rebbeck T, Neuhausen SL, Ghadirian P, Foulkes WD, Gershoni-Baruch R, Friedman E, Rennert G, Wagner T, Isaacs C, Kim-Sing C, Ainsworth P, Sun P, Narod SA.
    J Clin Oncol; 2005 Oct 20; 23(30):7491-6. PubMed ID: 16234515
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.